BioCentury
ARTICLE | Financial News

bluebird bio proposes IPO

May 20, 2013 7:00 AM UTC

bluebird bio Inc., Cambridge, Mass. Business: Gene/Cell therapy, Hematology, Neurology Date announced: 5/14/13 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: JPMorgan...